Genome & stock price
지놈앤컴퍼니KRX:314130 · KOSDAQ · HealthcareToday's signals · No active technical signal.
Signal details →Genome & last closed at ₩5,540 (+2.78%) on 2026-10-02. Listed on KOSDAQ. Trailing 12 months PER is -4.8×. Its overall grade ranks 243 of 306 stocks in Healthcare.
About this company
Genome & last closed at ₩5,540 (+2.78%) on 2026-10-02. Listed on KOSDAQ.
Details →Reported results
Position in sector
Healthcare · Overall C · 243/306
Valuation grade C+
Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- 마이크로바이옴 치료제Related theme
지놈앤컴퍼니의 핵심 연구개발 테마
- 면역항암제Related theme
주요 파이프라인이 속한 항암 치료 영역
- MerckCompetitor
면역항암제·항암 신약 개발에서 글로벌 경쟁사
About Genome &
- What technical signals does Genome & (314130) have?
- Genome & current technical signals: no active technical signal.
- Is Genome & a cup-and-handle pattern?
- No. Genome & has no valid Cup signal right now.
- What published figures are available for Genome &?
- Market cap: KRW 177.89B. Trailing 12 months PER: -4.8×. Latest quarter PBR: 2.75×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Genome &, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).